Zobrazeno 1 - 3
of 3
pro vyhledávání: '"AbouSherif, S"'
Autor:
Kilic İD, Hakeem A, Marmagkiolis K, Paixao A, Grunwald I, Mutlu D, AbouSherif S, Gundogdu B, Kulaksizoglu S, Ates I, Wholey M, Goktekin O, Cilingiroglu M
Stroke remains among the leading causes of disability and death worldwide. Fibrinolytic therapy is associated with poor patency and functional outcomes. Recently, multiple randomized trials have been published that have consolidated the role of endov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::aaccfb46fc2fb913a129782255e262da
Autor:
Kilic, ID, Hakeem, A, Marmagkiolis, K, Paixao, A, Grunwald, I, Mutlu, D, AbouSherif, S, Gundogdu, B, Kulaksizoglu, S, Ates, I, Wholey, M, Goktekin, O, Cilingiroglu, M
Stroke remains among the leading causes of disability and death worldwide. Fibrinolytic therapy is associated with poor patency and functional outcomes. Recently, multiple randomized trials have been published that have consolidated the role of endov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3810107b884b300e8534abfb7d2b684e
Autor:
Kilic, İ.D., Hakeem, A., Marmagkiolis, K., Paixao, A., Grunwald, I., Mutlu, D., AbouSherif, S., Gundogdu, B., Kulaksizoglu, S., Ates, I., Wholey, M., Goktekin, O., Cilingiroglu, M.
Stroke remains among the leading causes of disability and death worldwide. Fibrinolytic therapy is associated with poor patency and functional outcomes. Recently, multiple randomized trials have been published that have consolidated the role of endov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::13dce866588bc3dd9a184242ae5b94bf